[1] EsnaolaNF, MeyerJE, KarachristosA, et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma[J]. Cancer, 2016, 122(9):1349-1369.
[2] Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma[J]. Semin Liver Dis, 2004, 24(2):189-199.
[3] Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocarcinoma[J]. Surg Clin North Am, 2010, 90(4): 817-837.
[4] LafaroKJ, CosgroveD, GeschwindJF, et al. Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management[J]. Gastroenterol Res Pract, 2015, 2015:860-861.
[5] Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell 2010, 140(6):883-899.
[6] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203):436-444.
[7] Deans C, Wigmore S J. Systemic inflammation, cachexia and prognosis in patients with cancer[J]. Current Opinion in Clinical Nutrition and Metabolic Care, 2005, 8(3):265-269.
[8] Chen Y, Zhang L, Liu W X, et al. Prognostic Significance of Preoperative Anemia, Leukocytosis and Thrombocytosis in Chinese Women with Epithelial Ovarian Cancer[J]. Asian Pacific journal of cancer prevention: APJCP, 2015, 16(3):933-939.
[9] Obermair A, Petru E, Windbichler G, et al. Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer[J]. Oncology Reports, 2000, 7(3):639-644.
[10] Templeton A J, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis[J]. Cancer Epidemiol Biomarker Prev, 2014, 23(7):1204-1212.
[11] Li J, Jiang R, Liu W-S, et al. A large cohort study reveals the association
of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma[J]. PLoS One, 2013, 8(12): e83069.
[12] Zhou X, Du Y, Huang Z, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 2014;9:e101119.
[13] Salvagno G L, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications[J]. Critical Reviews in Clinical Laboratory Sciences, 2015, 52(2):86-105.
[14] Felker G M, Allen L A, Pocock S J, et al. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure: Data From the CHARM Program and the Duke Databank[J]. Journal of the American College of Cardiology, 2007, 50(1):40-47.
[15] Montagnana M, Cervellin G, Meschi T, et al. The role of red blood cell distribution width in cardiovascular and thrombotic disorders[J]. Clinical Chemistry and Laboratory Medicine, 2012, 50(4):635-641.
[16] Tham T, Bardash Y, Teegala S, et al. The red cell distribution width as a prognostic indicator in upper aerodigestive tract (UADT) cancer: A systematic review and meta-analysis[J]. Am J Otolaryngol, 2018, 39(4):453-458.
[17] Hu L, Li M, Ding Y, et al. Prognostic value of RDW in cancers: a systematic review and meta-analysis[J]. Oncotarget, 2017, 8(9):16027-16035.
[18] Zhao T, Cui L, Li A. The significance of RDW in patients with hepatocellular carcinoma after radical resection[J]. Cancer Biomarkers, 2016, 16(4):507-512.
[19] Zhu Y, Li J H, Yang J, et al. Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection[J]. Medicine, 2017, 96(39):e8056.
[20] Hirahara N, Matsubara T, Kawahara D, et al. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma[J]. International Journal of Clinical Oncology, 2016, 21(5):909-919.
[21] Zhang F, Chen Z, Wang P, et al. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients[J]. Tumour Biol, 2016; 37(7): 9323-9331.
[22] Ichinose J, Murakawa T, Kawashima M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer[J]. Journal of Thoracic Disease, 2016, 8(12):3658-3666.
[23] Wang J, Xie X, Cheng F, et al. Evaluation of pretreatment red cell distribution width in patients with multiple myeloma[J]. Cancer Biomarkers, 2017, 20(3):267-272.
[24] Shota S, Saito H, Kono Y, et al. Prognostic Significance of Pre- and Post-operative Red-Cell Distribution Width in Patients with Gastric Cancer[J]. Journal of Gastrointestinal Surgery, 2019(2).:1-8.
[25] Kemal Y, Demirag G, Bas B, et al. The value of red blood cell distribution width in endometrial cancer[J]. Clinical Chemistry and Laboratory Medicine (CCLM), 2015, 53(5):823-827.
[26] Albayrak S, Zengin K, Tanik S, et al. Red Cell Distribution Width as a Predictor of Prostate Cancer Progression[J]. Asian Pacific journal of cancer prevention: APJCP, 2014, 15(18):7781-7784.
[27] Alvin Lee, Han Jie Lee, Hong Hong Huang, et al. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma[J]. Genitourinary Cancer, 2019,12(11):1-10.
[28] Ferrucci L, Guralnik JM, Woodman RC, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia[J]. The American Journal of Medicine, 2005, 118(11):1288.e11-1288.e19.
[29] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell. 2011; 144(5): 646-674.
[30] Semba R D, Patel K V, Ferrucci L, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: The Women's Health and Aging Study I[J]. Clinical Nutrition, 2010, 29(5):600-604.
[31] Wan GX, Chen P, Cai XJ, et al. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma. Clinica chimica acta; international journal of clinical chemistry. 2016; 452: 199-203.
[32] Perisa V, Zibar L, Sincic-Petricevic J, et al. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croatian medical journal. 2015; 56(4): 334-343.
[33] Meng S, Ma Z, Lu C, Liu H, Tu H, Zhang W, et al. Prognostic Value of Elevated Red Blood Cell Distribution Width in Chinese Patients with Multiple Myeloma[J]. Annals of clinical and laboratory science, 2017; 47(3): 282-290.
[34] Hirahara N, Matsubara T, Kawahara D, et al. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma[J]. International Journal of Clinical Oncology, 2016, 21(5):909-919.
[35] Zhang F, Chen Z, Wang P, et al. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients[J]. Tumor Biology, 2016.
[36] Sun P, Zhang F, Chen C, et al. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China[J]. Oncotarget, 2016, 7(27):42650-42660.
[37] Wang, P-F, Song, S-Y, Guo H, et al. Prognostic role of pretreatment red blood cell distribution width in patients with cancer: A meta-analysis of 49 studies[J]. Journal of Cancer, 2019; 10(18): 4305-4317.